Alkermes Pharma Ireland filed suit against Teva Pharmaceuticals over two patents related to multiparticulate modified release compositions. 12/1, District of Delaware, 1:2011cv01186.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
